Abstract
Vaccine hesitancy is context specific and varies over time and space. Therefore, strategies to tackle vaccine hesitancy based on evidence from high income countries are unlikely to serve the purpose adequately in LMICs. We use district level evidence on COVID-19 vaccine uptake rates from an LMIC - India to provide evidence of COVID-19 vaccine hesitancy. We argue that vaccination rates during the different phases of COVID-19 vaccination across the districts is likely to be related to vaccine hesitancy. Districts with larger rural population and lower literacy rates had lower vaccination rates. High past child immunization rates were positively correlated with COVID-19 vaccination uptake. Across the four phases of vaccination drive, vaccine hesitancy was the highest during the third phase of the vaccination drive, and therefore the above correlations were strongest during the third and the fourth phase. Measures of family planning indicators too seem to be correlated with vaccine uptakes during the third phase which indicate the regions most susceptible to vaccine hesitancy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study did not use primary data that required approval or exemption from the IRB / oversight body.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used in this study is in public domain. Data sources have been cited in the article.
